A Nationwide Analysis Evaluating the Safety of Using Acellular Dermal Matrix with Tissue Expander-Based Breast Reconstruction

Background  In March 2021, the United States Food and Drug Administration (FDA) safety communication cautioned against the use of acellular dermal matrix (ADM) products in breast reconstruction and reiterated that the FDA does not approve ADM use in breast surgery. This study aims to assess the safe...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Jessica, Moss, Whitney D., Pires, Giovanna R., Rhemtulla, Irfan A., Rosales, Megan, Stoddard, Gregory J., Agarwal, Jayant P., Kwok, Alvin C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical Publishers, Inc. 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747277/
https://www.ncbi.nlm.nih.gov/pubmed/36523919
http://dx.doi.org/10.1055/s-0042-1758638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747277/
https://www.ncbi.nlm.nih.gov/pubmed/36523919
http://dx.doi.org/10.1055/s-0042-1758638

Ejemplares similares